Global /Taiwan /Healthcare /Drug Manufacturers - General /6483

Original BioMedicals Co., Ltd.

6483

• TPEX: 6483 • Delayed

15.50TWD 2.7%

0.4899 USD

As of 20 June 2026, Original BioMedicals Co., Ltd. has a market cap of $31.8M USD, ranking #33833 globally and #2082 in Taiwan. It ranks #3061 in the Healthcare sector, and #1048 in the Drug Manufacturers - General industry.

Global Rank

33833

Country Rank

2082

Sector Rank

3061

Industry Rank

1048

Key Stats

Market Cap

$31.8MUSD

1.01B TWD

Enterprise Value

$27.59MUSD

872.85M TWD

Revenue (TTM)

$12.05KUSD

381.0K TWD

EBITDA (TTM)

-$3.16MUSD

-99.88M TWD

Net Income (TTM)

-$3.21MUSD

-101.51M TWD

PS Ratio

2639.1

PB Ratio

6.4

Company Profile

Country (HQ)

Taiwan

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Cliff C. Wang open_in_new

Employees

Founded

2011

Website

i-obm.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
2.7%	-0.7%	-0.7%	0.7%	37%	8.7%	19%	-23%	-23%

News

Markets

Exchange	Ticker	Price	Quotes
Taipei Exchange (TPEX) MIC: ROCO PRIMARY	6483 原創生醫股份有限公司 ISIN: TW0006483001 Shares Out.: Shares Outstanding: 66.742M¹ Shares Float: 32.245M² TV: TradingView: TPEX: 6483 SA: Stock Analysis: TPEX: 6483 YF: Yahoo Finance: 6483.TWO GF: Google Finance: TPEX: 6483 BA: Barron's: 6483 MS: Morningstar: ROCO: 6483	15.50 TWD	TV: TradingView: TPEX: 6483 SA: Stock Analysis: TPEX: 6483 YF: Yahoo Finance: 6483.TWO GF: Google Finance: TPEX: 6483 BA: Barron's: 6483 MS: Morningstar: ROCO: 6483

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Original BioMedicals Co., Ltd.

Original BioMedicals Co., Ltd., engages in the development of new drugs with non-new ingredients in Taiwan. It develops OBM-A01, for the treatment of acute radiation injury, including nuclear radiation and solar radiation exposed in space; OBM-B01, a cyanide compound drug for protection against toxic gases from fires; and CCM-CL, a cyclic polypeptide antibiotic. The company was founded in 2011 and is based in Tainan City, Taiwan.

Similar Companies

Industry: Drug Manufacturers - General (Taiwan)

Name	Market Cap (USD) diff.	PE	Country
PharmaEssentia Corp. TWSE: 6446	$7.76B 245.34B TWD 24K%	48.6	Taiwan
Lotus Pharmaceutical Co., Ltd. TWSE: 1795	$1.83B 57.95B TWD 6K%	12.2	Taiwan
Center Laboratories, Inc. TPEX: 4123	$920.72M 29.11B TWD 3K%	3.4	Taiwan
Lumosa Therapeutics Co., Ltd. TPEX: 6535	$805.08M 25.46B TWD 2K%	-	Taiwan
Oneness Biotech Co., Ltd. TPEX: 4743	$785.01M 24.82B TWD 2K%	-	Taiwan
TTY Biopharm Company Ltd. TPEX: 4105	$581.1M 18.38B TWD 2K%	11.8	Taiwan

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 2M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 2M%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 1M%	97.4	United States
Roche Holding AG SIX: RO	$318.3B 256.25B CHF 1M%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$284.64B 215.59B GBP 895K%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 862K%	15.1	United States

chevron_leftBack